Evidence map›Paper›PMID 34135915›Full record

ArticleFrontiers in immunology2021

Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature.

Tiina Kelkka, Paula Savola, Dipabarna Bhattacharya, Jani Huuhtanen, Tapio Lönnberg, Matti Kankainen, Kirsi Paalanen, Mikko Tyster, Maija Lepistö, Pekka Ellonen and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Tiina KelkkaHematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
Paula SavolaHematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
Dipabarna BhattacharyaHematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
Jani HuuhtanenHematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
Tapio LönnbergTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Matti KankainenHematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
Kirsi PaalanenRheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland.
Mikko TysterHematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
Maija LepistöInstitute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Pekka EllonenInstitute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Johannes SmolanderTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Samuli EldforsInstitute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Bhagwan YadavHematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
Sofia KhanTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Riitta KoivuniemiRheumatology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Christopher SjöwallDepartment of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden.
Laura L EloTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Harri LähdesmäkiDepartment of Computer Science, Aalto University School of Science, Espoo, Finland.
Yuka MaedaDivision of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Japan.
Hiroyoshi NishikawaDivision of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Japan.
Marjatta Leirisalo-RepoRheumatology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Tuulikki Sokka-IslerRheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland.
Satu MustjokiHematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2020.578848.].

Indexed as

ACPA-negativeCD8+ lymphocyterheumatoid arthritisseronegativesomatic mutationT cell receptor

Identifiers

PMID34135915
PMCPMC8202119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.